VA PRIME Care Study Evaluates Pharmacogenomic Tests
Access to Myriad Genetics’ GeneSight test improves depression remission rates according to a new nationwide study of nearly 2,000 veterans conducted by the U.S. Department of Veterans Affairs (VA)
Videos
GeneSight b-roll
Soundbites from GeneSight clinicians
Visuals
Myriad Genetics logo
(full-color, white, and black)
GeneSight logo
(full-color, white, and black)
Media Contacts
Megan Manzari
(385) 318-3718
Megan.Manzari@myriad.com
Sharvari Dayal
(330) 354-7150
Sharvari.Dayal@myriad.com
Investor Contacts
Foster Harris
(919) 998-8379
Foster.Harris@myriad.com
GeneSight clinical studies 
VA PRIME Care release 
Learn more about the GeneSight test 
See a sample report 
GeneSight News 
Myriad Genetics 
Clinician stories